As Victor Wembanyama continues to display a career year on the court and win the hearts of many as the one to carry the NBA into the future, he is alrewady also ...
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
There is some outside buzz related to teams trying to trade for Myles Turner. The question is, why would the Indiana Pacers do this? Hint, it's likely to never occur.